heterodimers. Thus, calreticulin is unable to discriminate between native and non-native MHC class I conformations and therefore unlikely to play a role in the recognition and release of peptide-loaded complexes from the ER. Furthermore, the recombinant expression system developed in this study can be used to produce a broad range of calreticulin substrates to elucidate its general mechanism of activity in vitro.
INTRODUCTION
Calreticulin and calnexin are expressed in the endoplasmic reticulum (ER) and assist in the folding and assembly of newly synthesized glycoproteins. They function as lectin-like chaperones as part of an ER quality control system that couples the processing of N-linked glycans with protein folding (1, 2) . These chaperones also associate with ERp57, an ER thiol oxidoreductase, and together they cooperate in proper disulfide bond formation in newly synthesized glycoproteins. Calreticulin, a soluble ER resident protein, shares considerable sequence and structural homology with the lumenal domain of calnexin, an ER transmembrane protein. Both chaperones are predicted to possess a globular domain with an extended arm comprised of proline-rich repeats known as the P domain (3, 4) . The globular domain possesses the lectin-like binding site with a specificity for monoglucosylated glycans (3, 5) and the Pdomain has been mapped as the site of interaction with ERp57 (6).
In the ER glycoprotein quality control cycle (2) , the core Glc 3 Man 9 GlcNAc 2 oligosaccharide is transferred to newly synthesized proteins and quickly trimmed by glucosidases I and II to the Glc 1 Man 9 GlcNAc 2 processing intermediate which is the specific ligand of calreticulin and calnexin. Associated ERp57 catalyzes the formation or rearrangement of disulfide bonds within the folding glycoprotein via covalent intermediates. It has yet to be conclusively established if trimming of the terminal glucose by glucosidase II induces or follows dissociation of substrate from the chaperones. An affinity in the mM range for monoglucosylated proteins (7) might allow an equilibrium between bound and free glycoprotein, thus providing sufficient free material to serve as a substrate for glucosidase II. Nonetheless, if the released and de-glucosylated glycoprotein does not acquire its native state, it is re-glucosylated by UGGT (UDP-glucose: glycoprotein glucosyltransferase) which allows it to re-engage with calnexin or One question not yet resolved is whether calreticulin and calnexin can act as folding sensors in addition to UGGT. Two conflicting models have been proposed for their role in the quality control pathway (1) . In the lectin only model, calreticulin and calnexin interact solely with the monoglucosylated glycan and are not capable of discriminating between conformational states of a protein. In contrast, the dual binding model proposes that they recognize and bind to polypeptide-based determinants in addition to the oligosaccharide, and thus behave more like classical chaperones. To date, it has not yet been possible to resolve this debate with the available experimental substrates and methods.
The Major Histocompatibility Complex (MHC) class I molecule was one of the first substrates of calnexin and calreticulin to be identified and has been extensively studied as an in vivo model of ER quality control (11). It is a trimeric complex composed of a glycosylated heavy chain (HC), b 2 -microglobulin (b 2 m), and an 8-10 amino acid peptide, which is expressed on the surface of most cells and presents peptides derived from viral antigens to cytotoxic CD8+ T cells. The peptides are generated from cytosolic proteins by the proteasome and translocated via the transporter associated with antigen processing (TAP) into the ER where they may be
Radiolabeling and Immunoprecipitation
Human cell lines: .220.B8 cells were harvested and depleted for 1 h in methionine-free Dulbecco's Modified Eagle's Medium. Cells were pulse labeled with 1 mCi/ml [ raffinose medium with 1 mg/ml methionine and chased for up to 90 min. Cell lysates were prepared as described for the yeast purification and immunoprecipitation was performed using the 3B10.7 Ab.
Glycan Analysis
Glycan analysis was performed essentially as previously described (20) . Briefly, purified GS-B8 was precipitated with 10% TCA and separated by SDS-PAGE (25). The band was excised and digested with N-glycanase F. The released glycans were extracted, dried and fluorescently labeled with 2-aminibenzamide by reductive amination (26) and then separated by NP-HPLC using a TSK amide-80 4.6x250mm column (Tosoh Bioscience, Japan) calibrated using a dextran ladder (27). Digestions with Jack bean mannosidase and a-1,3 glucosidase II were performed as described (20) .
Refolding of MHC class I complexes
The refolding of MHC class I complexes was performed essentially as described (28) using human b 2 m purified from E. coli inclusion bodies with either GS-B8 to generate glycosylated complexes or NGS-B8 to generate non-glycosylated complexes. The NP380-388 peptide was synthesized by the Keck facility (Yale University). Final concentrations of 1 mM The calreticulin specifically associated with MHC class I HC was eluted by incubation with 10 mM EDTA in TBS for 5 min at RT and counted using a gamma counter. Calreticulin was released from the class I molecules by the addition of 10 mM EDTA in TBS for
RESULTS

Expression of MHC class I HC in S. cerevisiae glycosylation mutants
Certain MHC class I alleles are more dependent than others on the peptide loading complex for high affinity peptide binding and might therefore form more stable interactions with loading complex components in vitro. We chose to express recombinant HLA-B8 molecules, which have reduced cell surface expression in the tapasin-negative .220 cell line and are readily detected in association with the loading complex (15, 30) . Since glycan processing has been reported to variably affect the association of different MHC class I alleles with calnexin (31), we confirmed by co-immunoprecipitation that the interaction of HLA-B8 with the peptide loading complex in .220 cells was dependent on glycosylation and glucose trimming (data not shown).
These findings were in agreement with our previous studies of HLA-A3 (17).
To express MHC class I HC with the glycan structure Glc 1 Man 9 GlcNAc 2 we took advantage of S. cerevisiae mutants missing several genes in the pathways for the biosynthesis and processing of N-linked oligosaccharides (21) . The genotypes of the yeast strains used in this study are detailed in Table 1 . The YG556 strain has no glycosylation mutations and was used as a control. YG562 is a related strain with deletions of the ALG8 and GLS2 genes. As illustrated in Mannose trimming of N-linked glycans is one of the signals targeting misfolded ER proteins for retrotranslocation to the cytosol and degradation (34). In mammalian cells, inhibitors of the ER a-mannosidase, e.g. deoxymannojirimycin (DMM), can stabilize such proteins. In the 220.B8 cell line which lacks tapasin, HLA-B8 is unstable in the absence of high affinity peptide loading (Fig. 2c and data not shown) . However, it was stabilized by 1 mM DMM as determined by metabolic labeling and immunoprecipitation over a 3 h chase (Fig. 2c ).
This suggests that unassembled MHC class I HC are degraded by an a-mannosidase-dependent pathway, as was observed for HLA-B27 translated in vitro with canine microsomes (35) . Since deletion of the MNS1 gene which encodes the ER mannosidase stabilizes misfolded glycoproteins in yeast (23), we predicted that this mutation would improve the expression of HLA-B8 in S. cerevisiae. The novel strain YG780 was generated by introducing into the Dalg8 Dgls2 double mutant background the additional deletion of MNS1 to preserve the Man 9 structure.
As seen in Fig. 2a , steady state expression of both GF-B8 and GS-B8 was dramatically increased in YG780 cells, typically 10-fold. This could be attributed to the prolonged half-life of HLA-B8 in YG780 versus YG562 as determined by pulse-chase and immunoprecipitation (Fig. 2b) .
To address whether HLA-B8 molecules expressed in these yeast strains were efficiently glycosylated, immunoprecipitated class I HC were incubated in the absence or presence of Endo H (Endoglycosidase H), which cleaves high mannose N-linked oligosaccharides, prior to SDS-PAGE. For all three strains, a single predominant band was observed that increased in mobility upon Endo H digestion (Fig. 2d) . Thus, virtually all of the GS-B8 molecules were modified with a single N-linked glycan. This was fortunate since incomplete core oligosaccharides can be transferred to newly synthesized proteins with reduced efficiency (21) .
Purification and characterization of soluble MHC class I HC from YG780
Recombinant GS-B8 was isolated from transformed YG780 cells using immunoaffinity and Ni-NTA agarose chromatography. As a non-glycosylated control, an analogous construct, NGS-B8, (see Fig. 1b ) was expressed in E. coli, solubilized under identical conditions and purified using Ni-NTA agarose. Fig. 3 shows a Coomassie Blue-stained SDS-PAGE gel of the purified proteins and a Western blot with the 3B10.7 Ab to confirm their identity. As expected, GS-B8 migrates with a slower mobility and is recognized by the lectin Concanavalin A because it has a single N-linked glycan (Fig. 3) .
The oligosaccharides associated with purified GS-B8 were released by N-glycanase F treatment and separated by normal phase (NP)-HPLC. Preliminary structural assignments were made from the glucose unit (GU) values of each peak calculated using a dextran ladder as a calibration standard (27). The structures were confirmed by exoglycosidase digestion and the details are summarized in Table 2 . The major peak (peak 3: 83.8% area) is the fraction containing Glc 1 Man 9 GlcNAc 2 as seen by its shift of 1 GU when treated with glucosidase II (Fig.   4 a and c) . The core Man 9 GlcNAc 2 was confirmed by Jack bean a1,2,3,6 mannosidase digestion which generated the structures Man 4 GlcNAc 2 and the incompletely digested Man 5 GlcNAc 2 as shown in Fig 4b. MALDI mass spectra were consistent with this assignment (data not shown).
Other minor species were present, including Glc 1 Man 8 GlcNAc 2 and Glc 1 Man 10 GlcNAc 2, (Fig.   4a , peaks 2 and 4 respectively). When these are included in the calculation, 93% of the total GS-B8 bears a monoglucosylated N-linked glycan.
Calreticulin binds to glycosylated, but not non-glycosylated MHC class I HC
Several assays were developed to characterize the interaction of calreticulin with recombinant MHC class I molecules. The first was a pulldown assay (Fig. 5a ) in which GS-B8, NGS-B8, or BSA as a control, were bound to 3B10.7 beads to immobilize the class I HC. The beads were then incubated with purified recombinant human calreticulin for 1 h at RT and washed with ice-cold buffer. Bound proteins were resolved by SDS-PAGE and analyzed for the presence of calreticulin by immunoblotting. As shown in Fig. 5a , calreticulin specifically associated with GS-B8 in a dose-dependent fashion. Even upon longer exposures, no binding was observed to the non-glycosylated HLA-B8 purified from E coli.
To evaluate the contribution of the glycan to calreticulin binding, purified MHC class I HC or control proteins were coated onto a 96-well plate and treated with either no enzyme, Endo H or a-glucosidase. Calreticulin was added to the wells for 1 h at RT and bound protein was detected by ELISA using an anti-calreticulin Ab. As seen in Fig. 5b and c, only background levels of binding were observed for BSA, b 2 m and the E. coli-expressed NGS-B8. Calreticulin clearly bound, however, to GS-B8. Binding was completely eliminated by the removal of either the N-linked glycan with Endo H (Fig. 5b) or the glucose residue with a-glucosidase (Fig. 5c) . To test the ability of calreticulin to discriminate between various folding states of MHC class I molecules, free HC, free b 2 m, empty heterodimers or peptide-loaded complexes were coated onto an ELISA plate. All refolded samples were passed over 3B10.7 beads immediately prior to the experiment to remove any free HC that may have dissociated from the complexes.
As shown by the ELISA in Fig. 6b, calreticulin associated 
Quantitation of calreticulin binding to native and non-native MHC class I molecules
To directly determine the affinity of calreticulin for free class I HC with or without the glycan, a spin column binding assay was employed using [ (representing a 1 mg/ml solution) even when the washing steps were reduced or eliminated (data not shown). We conclude that if a glycan-independent interaction between calreticulin and nonnative MHC class I molecules exists, its affinity is more than an order of magnitude lower than that for the glycosylated substrate. Furthermore, it is clear that the ELISA and pulldown assays can detect calreticulin interactions in the low mM affinity range.
To investigate the possibility that both lectin and polypeptide-based interactions contribute to the association of calreticulin with non-native GS-B8 molecules, the binding to Following brief washing, the associated calreticulin was eluted from the wells and counted. As seen in Fig. 7b (left panels) , calreticulin binding to free class I HC and refolded complexes displayed similar saturation curves. Scatchard analysis of the binding data (Fig. 7b, right 
DISCUSSION
In vitro binding studies of calreticulin and calnexin with purified substrates have been limited to date to non-glycosylated proteins and a small handful of glycoproteins that can either be isolated with glycans naturally in the Gluc 1 Man 7-9 GlcNAc 2 state or that can be regenerated with UGGT in vitro (36) (37) (38) (39) . The yeast glycosylation mutants described here dramatically increase the range of potential substrates. Ninety three percent of HLA-B8 molecules expressed in a S. cerevisiae strain with deletions of ALG8, GLS2, and MNS1 bear a monoglucosylated Nlinked glycan ( Golgi, where the addition of additional mannose residues is well documented in yeast (40) .
MHC class I molecules are an excellent model system for the study of the lectin-like chaperones since they interact with both calnexin and calreticulin during their assembly and folding intermediates can be reconstituted in vitro with b 2 m and peptide. By combining this with the mutant yeast expression system, we have been able to characterize the structural and glycosylation requirements for the interaction of calreticulin with MHC class I molecules independently of the other components of the peptide loading complex. We found that calreticulin only associated with the glycosylated HLA-B8 expressed in yeast and not with the non-glycosylated protein isolated from E. coli (Fig. 5 and 6 ). Complete removal of the glycan or minimal perturbation by removal of the single glucose eliminated the interaction. Furthermore, calreticulin associated equally well with the glycosylated versions of fully denatured class I HC, peptide-free HC-b 2 m heterodimers, and native, peptide-loaded complexes, indicating that calreticulin does not discriminate between native and non-native conformations ( Fig. 6 and 7) .
The monoglucosylated N-linked glycan alone is necessary and sufficient for calreticulin binding.
Two prevailing models for the mechanism of calreticulin and calnexin activity have been proposed and debated. In the lectin only model, calreticulin and calnexin recognize glycans with the properly trimmed monoglucosylated structure and are insensitive to the conformational state of a glycoprotein. Evidence for this model is that inhibitors of glycosylation and glucose trimming eliminate the association of folding substrates with calreticulin and calnexin (41, 42) .
In addition, the association of calnexin with RNase B in vitro was found to be strictly dependent on the glycan (36, 43) . In the dual binding model, association is initiated by binding to the glycan which is then followed by polypeptide-based interactions. Evidence for the latter model is that calreticulin and calnexin can retain association with some glycoproteins following removal of the N-linked glycan with Endo H (44-46). Furthermore, it has been proposed that calreticulin and calnexin possess classical chaperone activity because they can suppress the aggregation of nonglycosylated proteins in vitro (37, 47) . The discrepancies between these two models are generally attributed to the differences and limitations of the experimental approaches employed.
It is also possible that the nature of calreticulin or calnexin interactions will vary for different glycoproteins.
Our observations are in excellent agreement with previous in vitro studies supporting the lectin only model (36, 38, 43) . We found no evidence for the interaction of calreticulin with nonglycosylated MHC class I HC (Fig. 5 and 6 ). This is consistent with the finding that tunicamycin and castanospermine eliminate the interaction of MHC class I heterodimers with the peptide loading complex in vivo ( (17); and data not shown). No binding to NGS-B8 was observed at concentrations up to 20 mM calreticulin (data not shown) which represents the limit of our assay system. Other methods are available that can measure lower affinities and faster off-rates, but they require very large quantities of protein and are frequently bedeviled by ligand aggregation problems at high protein concentrations.
The complex between calreticulin and glycosylated HLA-B8 was quite stable, surviving We recently determined the structure of the glycans present on MHC class I HC associated with the peptide loading complex (20) . Approximately half of the class I molecules were in the monoglucosylated state (Glc 1 Man 8-9 GlcNAc 2 ), consistent with the notion that calreticulin associates with class I HC via its N-linked glycan. However, the remaining molecules were non-glucosylated (Glc 0 Man 6-9 GlcNAc 2 ). Several explanations exist for this observation. First, calreticulin may be present in the purified loading complexes in substoichiometric amounts. This was indeed observed in the initial analysis of the composition of the peptide loading complex (30), and is also supported by the finding that the murine MHC class I peptide loading complex can assemble in calreticulin-negative cells (51). Second, calreticulin may be tethered to the loading complex via low affinity interactions with ERp57, which is covalently associated with the tapasin in the complex by a disulfide bond (19) . Third, it could be explained by non-glycan mediated interactions between calreticulin and class I HC following glucosidase trimming. This is not supported by the data presented here, although it cannot be excluded that the MHC class I conformation in the peptide loading complex might be altered such that a very low affinity protein-protein interaction with calreticulin is facilitated.
Nonetheless, we favor a model in which the association of calreticulin with the MHC class I molecule is regulated by glucose trimming and readdition and a factor other than calreticulin, perhaps UGGT, is the sensor for the peptide occupancy of MHC class I molecules associated with the loading complex. The interaction of MHC class I with tapasin and/ or ERp57 may be altered upon peptide binding so as to induce dissociation from the loading complex and transport to the Golgi. The function of calreticulin within the loading complex may simply be to recruit ERp57 which rearranges disulfide bonds within tapasin and the class I HC (19).
In conclusion, our studies using recombinant MHC class I molecules with genetically Immunoprecipitated HC were incubated with or without Endo H and analyzed by SDS-PAGE. 
